This Policy Insight outlines eight questions that are likely to shape the U.S. global health response in the last two years of the current presidential term and beyond.
- state & global data
- view as grid
- view as list
In the latest post in the Policy Insights series, Jen Kates and Josh Michaud outline eight questions that are likely to shape the U.S. global health response in the last two years of the current presidential term and beyond. Follow Jen Kates and Josh Michaud on Twitter, and access previous columns…
This policy insight examines the unexpected drop in Medicare’s per-beneficiary spending projections and its implications for beneficiaries and the program’s future.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed. All previous columns by Drew Altman are available online.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed.
This fact sheet provides an overview of spending on the Medicare program and how the program is financed. It examines historical, recent, and future trends in Medicare spending, including the recent slowdown partially attributable to provisions in the Affordable Care Act of 2010, and includes the latest available data on Medicare financing.
On Monday, July 14, 2014, the Kaiser Family Foundation and the Alliance for Health Reform will host a briefing to discuss CHIP, and why it was created, as well as experiences with children’s coverage through CHIP and Medicaid, and some of the key policy and financing questions around children’s health coverage looking forward.
This brief examines the latest Congressional Budget Office (CBO) projections for federal Medicaid and CHIP spending over the 2014-2024 period. CBO’s budget projections, also known as “baseline” projections, reflect CBO’s best judgment about how the economy and other factors will affect federal revenues and spending under existing laws. The brief also examines CBO estimates of the coverage effects of the Affordable Care Act (ACA) on Medicaid and CHIP enrollment and spending. Understanding the CBO baseline estimates is important because they are the basis to evaluate the federal cost and coverage implications of proposed federal policy changes.
This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.